| Name | v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) |
| Symbol | ERBB2 |
| Aliases | NEU; NGL; HER2; HER-2; Avian erythroblastic leukemia viral (v-erb-b2) oncogene homolog 2; v-erb-b2 avian erythroblastic leukemia viral oncogene homolog 2 (neuro/glioblastoma derived oncogene homolog) |
| Gene Product | - v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog
|
| Category | - Amplification in Prostate cancer
|
| UniGene | Hs.323910 |
| OMIM | 164870 |
| Locus | 2064 |
| Summary | Tyrosine kinase receptor, a component of IL-6 signalling through the MAP kinase pathway; similar to the EGF receptor |
| Gene Ontology | |
| Expression | | EST (266 ESTs, 155 libraries) |
| Tissue ? |
Frequency ? |
Count ? |
| bone marrow (2/263) |  | 2/38555 |
| brain (5/204) |  | 6/362011 |
| colon (34/853) |  | 63/165626 |
| embryo (1/19) |  | 4/37976 |
| eye (4/33) |  | 10/93836 |
| head and neck (8/990) |  | 12/79796 |
| heart (1/22) |  | 2/55494 |
| intestine (1/4) |  | 4/11528 |
| kidney (3/86) |  | 3/132968 |
| lung (5/312) |  | 9/245386 |
| muscle (2/21) |  | 7/71297 |
| nervous (1/475) |  | 1/43438 |
| oral cavity (1/18) |  | 2/44567 |
| ovary (4/144) |  | 7/81880 |
| pancreas (4/33) |  | 7/117255 |
| placenta (14/342) |  | 20/157762 |
| prostate (5/291) |  | 7/109871 |
| skin (1/31) |  | 1/100815 |
| spleen (1/7) |  | 1/9511 |
| stomach (9/312) |  | 13/129930 |
| testis (1/171) |  | 3/117531 |
| uncharacterized tissue (41/1773) |  | 73/713325 |
| uterus (5/212) |  | 7/155110 |
|
| SAGE (8882218 tags, 180 libraries) |
| Tissue ? |
Frequency ? |
Count ? |
| brain (13/19) |  | 27/1157884 |
| cerebellum (1/1) |  | 2/102560 |
| colon (8/8) |  | 24/837255 |
| eye (5/6) |  | 7/489513 |
| heart (1/1) |  | 3/253071 |
| kidney (2/2) |  | 4/73935 |
| liver (1/1) |  | 3/200583 |
| lung (1/1) |  | 4/178286 |
| mammary gland (12/19) |  | 108/1358570 |
| muscle (2/2) |  | 38/269309 |
| ovary (6/10) |  | 15/313345 |
| pancreas (7/8) |  | 26/478962 |
| prostate (11/13) |  | 47/958610 |
| skin (4/7) |  | 6/62013 |
| stomach (2/3) |  | 16/409395 |
| uncharacterized tissue (17/22) |  | 118/1610180 |
| vascular (2/3) |  | 2/128747 |
|
|
| SNP | rs272159 (G/A:exception);  rs1058808 (C/G:exception);  rs2952154 (G/A:exception);  rs2904764 (G/A:locus-region);  rs2313170 (A/G:exception);  rs1565923 (A/G:exception);  rs445358 (A/G:exception);  rs2643193 (A/G:locus-region);  rs2517951 (T/C:locus-region);  rs2088126 (A/G:exception);  rs1801200 (G/A:exception);  rs387082 (T/N:exception);  rs169244 (G/A:exception);  rs1810132 (C/T:exception);  rs2172826 (C/G:exception);  rs2230700 (G/T:mrna-utr);  rs2934967 (G/T:locus-region);  rs903506 (A/G:exception);  rs2517959 (C/A:locus-region);   |
| Evidence | Amplification in Prostate cancer
|